Rhabdomyolysis as an uncommon manifestation of anoctamin-5 muscular dystrophy

Anoctamin-5 (ANO5) muscular dystrophy is a rare neuromuscular disease originated by homozygous mutations in ANO5, a gene encoding a protein with the same name located on chromosome 11. ANO5 is a calcium-activated chloride channel that is highly expressed in heart and skeletal muscle. It is a rare cause of inherited rhabdomyolysis. Understanding this phenotype is crucial for accurate and timely diagnosis.We must emphasize how meticulous medical history taking along with a high index of suspicion are essential to diagnose this disease.Currently, there is no specific treatment for this condition, but management should include avoiding heavy muscle training and use of statins.

Authors

Institutions

Publication Details

Journal
European Journal of Case Reports in Internal Medicine
Published
2025-03-28
DOI
https://doi.org/10.12890/2025_005325
Primary Topic
Muscle and Compartmental Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rhabdomyolysis as an uncommon manifestation of anoctamin-5 muscular dystrophy

Marta Rodrigues, Tiago R. D. Costa, António Mateus‐Pinheiro, Sónia Moreira
European Journal of Case Reports in Internal Medicine
Muscle and Compartmental Disorders
article

Rhabdomyolysis as an uncommon manifestation of anoctamin-5 muscular dystrophy

Marta Rodrigues, Tiago R. D. Costa, António Mateus‐Pinheiro, Sónia Moreira
article en

Abstract

Anoctamin-5 (ANO5) muscular dystrophy is a rare neuromuscular disease originated by homozygous mutations in ANO5, a gene encoding a protein with the same name located on chromosome 11. ANO5 is a calcium-activated chloride channel that is highly expressed in heart and skeletal muscle. It is a rare cause of inherited rhabdomyolysis. Understanding this phenotype is crucial for accurate and timely diagnosis.We must emphasize how meticulous medical history taking along with a high index of suspicion are essential to diagnose this disease.Currently, there is no specific treatment for this condition, but management should include avoiding heavy muscle training and use of statins.

European Journal of Case Reports in Internal MedicineVol. 12(4)
Hospital da Luz (PT)
Openalex Percentile: Top 90%
Muscle and Compartmental Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.